Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative NeoplasmsChloe Thompson-Peach(University of Adelaide), Danièl Thomas(Unknown)BIO-PROTOCOLJanuary 1, 202310.21769/bioprotoc.4592Cited by 1SaveCiteExport RISWatch citationsRelated PapersDysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability|Cancer Discovery|2022|59Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort|Blood Cancer Journal|2025|6